Detalles de la búsqueda
1.
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes.
Gut
; 73(5): 835-843, 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253482
2.
Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase-4 inhibitors: Real world evidence from the Nordic EMPRISE study.
Diabetes Obes Metab
; 25(1): 261-271, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36097728
3.
Economic burden of osteoarthritis - multi-country estimates of direct and indirect costs from the BISCUITS study.
Scand J Pain
; 23(4): 694-704, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381657
4.
Burden of disease and management of osteoarthritis and chronic low back pain: healthcare utilization and sick leave in Sweden, Norway, Finland and Denmark (BISCUITS): study design and patient characteristics of a real world data study.
Scand J Pain
; 23(1): 126-138, 2023 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858277
5.
Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register.
Diabetes Care
; 42(4): 545-552, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30705062
Resultados
1 -
5
de 5
1
Próxima >
>>